bupranolol and oxytocin
bupranolol has been researched along with oxytocin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Doheny, HC; Lynch, CM; Morrison, JJ; Smith, TJ | 1 |
| Clouse, AK; Hieble, JP; Riedel, E; Westfall, TD | 1 |
Other Studies
2 other study(ies) available for bupranolol and oxytocin
| Article | Year |
|---|---|
Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Dose-Response Relationship, Drug; Electrophysiology; Ethanolamines; Female; Humans; In Vitro Techniques; Isometric Contraction; Membrane Potentials; Muscle Cells; Muscle Relaxation; Myometrium; Oxytocin; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Propanolamines; Receptors, Adrenergic, beta-3; Uterine Contraction; Uterus | 2005 |
The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Dose-Response Relationship, Drug; Ethanolamines; Female; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Myometrium; Oxytocics; Oxytocin; Potassium Chloride; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Ritodrine; Urinary Bladder; Uterine Contraction | 2007 |